+Compare
BHC
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
2.51B

BHC Bausch Health Companies Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for BHC with price predictions
07:00 PM EST Dec 05, 2023

BHC saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for BHC moved out of overbought territory on December 06, 2023. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 58 similar instances where the indicator exited the overbought zone. In of the 58 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

BHC moved below its 50-day moving average on December 05, 2023 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BHC broke above its upper Bollinger Band on December 01, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BHC entered a downward trend on November 22, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 24, 2023. You may want to consider a long position or call options on BHC as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BHC just turned positive on November 17, 2023. Looking at past instances where BHC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BHC advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (47.989). P/E Ratio (13.387) is within average values for comparable stocks, (60.542). BHC's Projected Growth (PEG Ratio) (0.011) is slightly lower than the industry average of (2.883). BHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (0.292) is also within normal values, averaging (65.502).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NASDAQ:ZTS), Teva Pharmaceutical Industries Limited (NASDAQ:TEVA), Elanco Animal Health (NASDAQ:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NASDAQ:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.76B. The market cap for tickers in the group ranges from 246 to 82.08B. ZTS holds the highest valuation in this group at 82.08B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 28%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was -5%. INNPF experienced the highest price growth at 6,143%, while CNTRF experienced the biggest fall at -65%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -54%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 68
Price Growth Rating: 53
SMR Rating: 84
Profit Risk Rating: 91
Seasonality Score: 22 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

BHC is expected to report earnings to rise 1.94% to $1.05 per share on February 21

Bausch Health Companies BHC Stock Earnings Reports
Q4'23
Est.
$1.05
Q3'23
Beat
by $0.11
Q2'23
Beat
by $0.12
Q1'23
Missed
by $1.27
Q4'22
Missed
by $2.01
The last earnings report on November 02 showed earnings per share of $1.03, beating the estimate of 92 cents. With 1.25M shares outstanding, the current market capitalization sits at 2.51B.
A.I.Advisor
published Dividends

BHC paid dividends on December 22, 2010

Bausch Health Companies BHC Stock Dividends
А dividend of $1.00 per share was paid with a record date of December 22, 2010, and an ex-dividend date of November 10, 2010. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2150 Saint Elzear Boulvard West
Phone
+1 514 744-6792
Employees
19900
Web
https://www.bauschhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNINX43.120.15
+0.35%
Harbor International Retirement
REEBX52.50-0.03
-0.06%
American Funds Europacific Growth R2E
GXXIX11.80-0.02
-0.17%
abrdn US Sustainable Leaders InstlSvc
SPSCX18.15-0.05
-0.27%
Sterling Capital Behav Sm Cp Val Eq Intl
CFIMX123.21-0.69
-0.56%
Clipper

BHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHC has been loosely correlated with PAHC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BHC jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.56%
PAHC - BHC
34%
Loosely correlated
N/A
ELAN - BHC
32%
Poorly correlated
+0.08%
VTRS - BHC
31%
Poorly correlated
+0.83%
EBS - BHC
28%
Poorly correlated
+5.42%
CRON - BHC
27%
Poorly correlated
N/A
More

Groups containing BHC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.56%
eye
(undefined stocks)
46%
Loosely correlated
+1.57%
north america
(undefined stocks)
36%
Loosely correlated
-0.00%
pharmaceuticals
(undefined stocks)
34%
Loosely correlated
+0.32%
drugs
(undefined stocks)
34%
Loosely correlated
+1.33%
ophthalmology
(undefined stocks)
25%
Poorly correlated
+0.26%
More